HEADER HYDROLASE 08-SEP-15 5ANW TITLE MTH1 IN COMPLEX WITH COMPOUND 24 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MTH1,2-HYDROXY-DATP DIPHOSPHATASE, 8-OXO-DGTPASE, COMPND 5 NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 1, NUDIX MOTIF 1; COMPND 6 EC: 3.6.1.55, 3.6.1.56; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD KEYWDS HYDROLASE, NUDT1, NUDIX HYDROLASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.A.READ,J.BREED REVDAT 3 06-APR-16 5ANW 1 JRNL REVDAT 2 16-MAR-16 5ANW 1 HETATM REVDAT 1 02-MAR-16 5ANW 0 JRNL AUTH J.G.KETTLE,H.ALWAN,M.BISTA,J.BREED,N.L.DAVIES,K.ECKERSLEY, JRNL AUTH 2 S.FILLERY,K.M.FOOTE,L.GOODWIN,D.R.JONES,H.KACK,A.LAU, JRNL AUTH 3 J.W.NISSINK,J.READ,J.S.SCOTT,B.TAYLOR,G.WALKER,L.WISSLER, JRNL AUTH 4 M.WYLOT JRNL TITL POTENT AND SELECTIVE INHIBITORS OF MTH1 PROBE ITS ROLE IN JRNL TITL 2 CANCER CELL SURVIVAL. JRNL REF J.MED.CHEM. V. 59 2346 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26878898 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01760 REMARK 2 REMARK 2 RESOLUTION. 1.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,WOMACK; REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 COMPLETENESS FOR RANGE (%) : 79.71 REMARK 3 NUMBER OF REFLECTIONS : 24983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.2003 REMARK 3 R VALUE (WORKING SET) : 0.1989 REMARK 3 FREE R VALUE : 0.2253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.88 REMARK 3 FREE R VALUE TEST SET COUNT : 1218 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.37 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 21.77 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 756 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3693 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 724 REMARK 3 BIN R VALUE (WORKING SET) : 0.3707 REMARK 3 BIN FREE R VALUE : 0.3417 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.23 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 32 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1256 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.2861 REMARK 3 B22 (A**2) : 0.5173 REMARK 3 B33 (A**2) : -0.8033 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 0.0000 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.198 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.078 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.078 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.077 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.077 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.9419 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.9352 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1320 ; 2.00 ; HARMONIC REMARK 3 BOND ANGLES : 1804 ; 2.00 ; HARMONIC REMARK 3 TORSION ANGLES : 438 ; 2.00 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 31 ; 2.00 ; HARMONIC REMARK 3 GENERAL PLANES : 198 ; 5.00 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1320 ; 20.00 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 160 ; 5.00 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1494 ; 4.00 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.84 REMARK 3 REMARK 3 TLS DETAILS. REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|3 - A|156 } REMARK 3 ORIGIN FOR THE GROUP (A): 14.2828 19.7540 9.2814 REMARK 3 T TENSOR REMARK 3 T11: -0.0126 T22: 0.0017 REMARK 3 T33: -0.0076 T12: 0.0081 REMARK 3 T13: -0.0089 T23: 0.0027 REMARK 3 L TENSOR REMARK 3 L11: 0.8015 L22: 1.2662 REMARK 3 L33: 0.6698 L12: 0.4640 REMARK 3 L13: -0.0704 L23: -0.1466 REMARK 3 S TENSOR REMARK 3 S11: 0.0410 S12: 0.0228 S13: -0.0370 REMARK 3 S21: 0.0549 S22: 0.0030 S23: 0.0204 REMARK 3 S31: 0.0030 S32: -0.0375 S33: -0.0440 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 5ANW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-15. REMARK 100 THE PDBE ID CODE IS EBI-64964. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25048 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.37 REMARK 200 RESOLUTION RANGE LOW (A) : 61.10 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.0 REMARK 200 DATA REDUNDANCY : 5 REMARK 200 R MERGE (I) : 0.05 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.60 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 17.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.1 REMARK 200 R MERGE FOR SHELL (I) : 0.40 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 30.56500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.03500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.56500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.03500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DEETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2029 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2068 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 16 CG CD OE1 NE2 REMARK 470 ARG A 25 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 38 NZ REMARK 470 GLN A 54 CG CD OE1 NE2 REMARK 470 LYS A 66 CE NZ REMARK 470 GLU A 77 OE1 OE2 REMARK 470 ASP A 89 CG OD1 OD2 REMARK 470 GLU A 100 CG CD OE1 OE2 REMARK 470 ASP A 109 CG OD1 OD2 REMARK 470 LYS A 114 CG CD CE NZ REMARK 470 LYS A 130 CD CE NZ REMARK 470 LYS A 131 CD CE NZ REMARK 470 LYS A 138 NZ REMARK 470 GLU A 152 CG CD OE1 OE2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9CQ A1157 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ANU RELATED DB: PDB REMARK 900 MTH1 IN COMPLEX WITH COMPOUND 15 REMARK 900 RELATED ID: 5ANV RELATED DB: PDB REMARK 900 MTH1 IN COMPLEX WITH COMPOUND 15 DBREF 5ANW A 1 156 UNP P36639 8ODP_HUMAN 42 197 SEQADV 5ANW GLY A -1 UNP P36639 EXPRESSION TAG SEQADV 5ANW ALA A 0 UNP P36639 EXPRESSION TAG SEQRES 1 A 158 GLY ALA MET GLY ALA SER ARG LEU TYR THR LEU VAL LEU SEQRES 2 A 158 VAL LEU GLN PRO GLN ARG VAL LEU LEU GLY MET LYS LYS SEQRES 3 A 158 ARG GLY PHE GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY SEQRES 4 A 158 LYS VAL GLN GLU GLY GLU THR ILE GLU ASP GLY ALA ARG SEQRES 5 A 158 ARG GLU LEU GLN GLU GLU SER GLY LEU THR VAL ASP ALA SEQRES 6 A 158 LEU HIS LYS VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY SEQRES 7 A 158 GLU PRO GLU LEU MET ASP VAL HIS VAL PHE CYS THR ASP SEQRES 8 A 158 SER ILE GLN GLY THR PRO VAL GLU SER ASP GLU MET ARG SEQRES 9 A 158 PRO CYS TRP PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP SEQRES 10 A 158 MET TRP PRO ASP ASP SER TYR TRP PHE PRO LEU LEU LEU SEQRES 11 A 158 GLN LYS LYS LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY SEQRES 12 A 158 GLN ASP THR ILE LEU ASP TYR THR LEU ARG GLU VAL ASP SEQRES 13 A 158 THR VAL HET 9CQ A1157 23 HETNAM 9CQ 2-[4-(2-AMINOQUINAZOLIN-4-YL)PHENYL]-N,N- HETNAM 2 9CQ DIMETHYL-ACETAMIDE FORMUL 2 9CQ C18 H18 N4 O FORMUL 3 HOH *73(H2 O) HELIX 1 1 THR A 44 GLY A 58 1 15 HELIX 2 2 PRO A 112 ASP A 115 5 4 HELIX 3 3 ASP A 119 GLN A 129 1 11 SHEET 1 AA 2 TRP A 32 ASN A 33 0 SHEET 2 AA 2 ARG A 17 LYS A 23 1 O GLY A 21 N ASN A 33 SHEET 1 AB 2 MET A 101 GLN A 107 0 SHEET 2 AB 2 ARG A 17 LYS A 23 -1 O VAL A 18 N PHE A 106 SHEET 1 AC 7 THR A 144 VAL A 153 0 SHEET 2 AC 7 LYS A 132 GLN A 140 -1 O LYS A 132 N VAL A 153 SHEET 3 AC 7 HIS A 65 PHE A 74 1 O VAL A 67 N PHE A 133 SHEET 4 AC 7 LEU A 80 THR A 88 -1 O MET A 81 N PHE A 72 SHEET 5 AC 7 SER A 4 LEU A 13 1 O ARG A 5 N ASP A 82 SHEET 6 AC 7 ARG A 17 LYS A 23 -1 O LEU A 19 N VAL A 12 SHEET 7 AC 7 TRP A 32 ASN A 33 1 O ASN A 33 N GLY A 21 SHEET 1 AD 7 THR A 144 VAL A 153 0 SHEET 2 AD 7 LYS A 132 GLN A 140 -1 O LYS A 132 N VAL A 153 SHEET 3 AD 7 HIS A 65 PHE A 74 1 O VAL A 67 N PHE A 133 SHEET 4 AD 7 LEU A 80 THR A 88 -1 O MET A 81 N PHE A 72 SHEET 5 AD 7 SER A 4 LEU A 13 1 O ARG A 5 N ASP A 82 SHEET 6 AD 7 ARG A 17 LYS A 23 -1 O LEU A 19 N VAL A 12 SHEET 7 AD 7 MET A 101 GLN A 107 -1 O ARG A 102 N MET A 22 SHEET 1 AE 2 THR A 60 VAL A 61 0 SHEET 2 AE 2 ILE A 91 GLN A 92 -1 O GLN A 92 N THR A 60 SITE 1 AC1 14 THR A 8 LEU A 9 ASN A 33 GLY A 34 SITE 2 AC1 14 PHE A 35 GLY A 36 GLY A 37 PHE A 72 SITE 3 AC1 14 PHE A 74 TRP A 117 ASP A 119 ASP A 120 SITE 4 AC1 14 HOH A2022 HOH A2073 CRYST1 61.130 66.070 35.980 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016359 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015135 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027793 0.00000